RNA, U6atac small nuclear 12, pseudogene (RNU6ATAC12P)

RNA, U6atac small nuclear 12, pseudogene (RNU6ATAC12P) is a non-coding RNA pseudogene found in the human genome[1][7]. It is derived from the U6atac small nuclear RNA (snRNA) family, specifically related to the U6atac RNA sequence, which functions as part of the minor spliceosome. However, RNU6ATAC12P itself is classified as a pseudogene, meaning it does not produce a functional product and is not expressed as an active snRNA[1][2][7]. Pseudogenes like RNU6ATAC12P arise from retrotransposition or duplication events and are typically non-functional. While functional U6atac snRNAs play a crucial role in pre-mRNA splicing, this particular pseudogene does not contribute to spliceosomal activity and has no established biological or disease role or pharmacological relevance[1][2][5]. The presence of many copies of snRNA pseudogenes, such as RNU6ATAC12P, reflects retrotransposition dynamics in the genome but does not imply a functional or therapeutic role[2]. The term "pseudogene" explicitly indicates lack of coding potential or regulatory activity and distinguishes this sequence from functional RNA genes[1][2]. There are no known drugs, biomarkers, or safety concerns associated with this pseudogene; it is not considered a therapeutic target and does not interact with pharmacological agents[1][2]. Functional U6atac RNA is a catalytic component of the minor (U12-dependent) spliceosome involved in pre-mRNA splicing, but pseudogenes like RNU6ATAC12P are evolutionary remnants and not functional[5]. In summary, RNU6ATAC12P is a pseudogene related to the U6atac small nuclear RNA, with no protein product, biological function, or role in disease. It is not a therapeutic target and has no drug interactions, mechanisms of action, or safety concerns[1][2][7].

Other names

RNU6ATAC12P